Method Sign up free

Borrower record · Q2 2026

Riverpoint Medical

As filed by 2 BDCs · period end 30 June 2026NAICS 31-33 · Manufacturing

Two lenders report $49.3m of Riverpoint Medical at Q2 2026, marked at par. All of it comes due inside two years — the last tranche in June 2027.

Filed fair value
$49.3m
6 funded positions
Reporting lenders
2
across 8 filed positions
Aggregate mark
100.2c
covers 75% of positions with a filed cost
Median spread
450bp
over SOFR, 6 tranches
Maturities to
2027
one date, 21 June 2027
Periods on record
5
first filed Q2 2025

How this total is counted

Pricing as filed

6 floating tranches · SOFR

450bp on all 6 floating tranches — every filer reports the same spread.

Capital structure

First-Lien Senior Secured, on all 6 positions whose seniority a filer disclosed.

Rate structure

Floating, on all 6 positions whose interest type a filer disclosed.

Maturity profile

all 6 funded positions dated
2027
$49.3m

1.0 years to maturity, weighted by fair value across the 6 dated positions.

Credit flags

No lender reports this borrower on non-accrual, and no filed tranche pays in kind.

Not in the filings

Sign up for free

Who holds it, and where they mark it.

2 lenders hold the same credit and mark it differently. Behind the gate, one row each — for this borrower and for every other one on this site, free and with no limit on how many you read.

LenderPositionsFair valueMarkSpreadMaturityAccrual

Every filing behind this page

2 filers · Q2 2026
FilerCIKFormPeriodFiledAccession
Goldman Sachs BDC, Inc. (GSBD)000157269410-Q2026-06-302026-08-060001193125-26-338331
Goldman Sachs Private Middle Market Credit II LLC000177270410-Q2026-06-302026-08-110001193125-26-344590

Related borrowers

Same lenders

Same sector